The Effect of Calcium Adjustment on the Quality of Life of ESRD Patients Under 18 Years of Age

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Pediatrics, Child Health Promotion Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associate Professor, Department of Community and Preventive Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Student of Medicine, School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: With maximum well-being and comfort being key factors for improved quality of life of individuals with end-stage renal disease (ESRD), the potential benefits of any health care provided must be weighed carefully against possible side effects or disadvantages. It must be understood that the types of medical treatment, availability of support networks and financial resources, environmental conditions, as well as personal attributes can each significantly affect quality of life of those people living with the consequences of a chronic disease.Methods: This is a cross sectional study conducted in Alzahra Hospital, Isfahan, Iran, in 2010. All ESRD patients under 18 years of age were studied. At first, the level of serum calcium was measured for all patients, and quality of life was measured by pedsQL questionnaire. Then, all patients were treated for calcium disorders. After the intervention, the level of serum calcium and quality of life was measured. Finally all data were analyzed by SPSS software.Findings: The mean + SD score of quality of life before and after treatment for calcium disorders was 34.8 ± 24 and 53.3 ± 23 respectively; no statistically difference was seen before and after the intervention (P = 0.48). Conclusion: Although HRQOL is a useful appliance for improvement of quality of life in ESRD patients, other variables such as economic status, family awareness and family health status are also very important for improvement of QOL in patients with ESRD.

Keywords


  1. Schulman G, Himmelfarb J. Hemodialysis. In: Brenner BM, Rector FC, editors. Brenner and Rector's the kidney. 8th ed. Philadelphia: Saun-ders Elsevier; 2008. p. 2564, 2567.
  2. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 1998; 32(2): 278-83.
  3. Mitch WE. Chronic kidney disease. In: Goldman L, Ausiello DA, editors. Cecil Medicine. 23rd ed. Philadelphia: Sounders Elsevier; 2008. p. 921-31.
  4. Bloembergen WE, Port FK. Epidemiological per-spective on infections in chronic dialysis pa-tients. Adv Ren Replace Ther 1996; 3(3): 201-7.
  5. Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007. p. 2206-2219.
  6. Danese MD, Belozeroff V, Smirnakis K, Roth-man KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008; 3(5): 1423-9.
  7. Qunibi WY. Consequences of hyperphos-phatemia in patients with end-stage renal disease (ESRD). Kidney Int Suppl 2004; (90): S8-S12.
  8. Sanchez CP. Mineral metabolism and bone ab-normalities in children with chronic renal failure. Rev Endocr Metab Disord 2008; 9(2): 131-7.
  9. Noordzij M, Korevaar JC, Boeschoten EW, Dek-ker FW, Bos WJ, Krediet RT. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: asso-ciation with mortality in dialysis patients. Am J Kidney Dis 2005; 46(5): 925-32.
  10. Eiser C, Morse R. A review of measures of quali-ty of life for children with chronic illness. Arch Dis Child 2001; 84(3): 205-11.
  11. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4: 79.